Evelo Biosciences, Inc. Quarterly Current Ratio in % from Q3 2018 to Q3 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Evelo Biosciences, Inc. quarterly Current Ratio history and growth rate from Q3 2018 to Q3 2023.
  • Evelo Biosciences, Inc. Current Ratio for the quarter ending September 30, 2023 was 67.8 %, a 80.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 67.8 -278 -80.4% Sep 30, 2023
Q2 2023 109 -300 -73.4% Jun 30, 2023
Q1 2023 213 -244 -53.5% Mar 31, 2023
Q4 2022 343 -217 -38.8% Dec 31, 2022
Q3 2022 346 -197 -36.3% Sep 30, 2022
Q2 2022 408 -170 -29.5% Jun 30, 2022
Q1 2022 457 -125 -21.5% Mar 31, 2022
Q4 2021 561 +40.5 +7.79% Dec 31, 2021
Q3 2021 543 -104 -16% Sep 30, 2021
Q2 2021 579 -160 -21.6% Jun 30, 2021
Q1 2021 582 -281 -32.6% Mar 31, 2021
Q4 2020 520 -548 -51.3% Dec 31, 2020
Q3 2020 647 -611 -48.6% Sep 30, 2020
Q2 2020 739 -696 -48.5% Jun 30, 2020
Q1 2020 863 -832 -49.1% Mar 31, 2020
Q4 2019 1.07K -932 -46.6% Dec 31, 2019
Q3 2019 1.26K -723 -36.5% Sep 30, 2019
Q2 2019 1.43K Jun 30, 2019
Q1 2019 1.7K Mar 31, 2019
Q4 2018 2K Dec 31, 2018
Q3 2018 1.98K Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.